RAC1 and hepatocellular carcinoma: To date, several studies have shown that TIPE1 can inhibit the activation of Rac1, its downstream target p65, and the c-Jun N-terminal kinase pathway in hepatocellular carcinoma cells (12) and decrease mTOR phosphorylation by stabilizing TSC2 protein in a Parkinson's disease model (17).